Back

dr. M. (Martin) Teraa

Assistant Professor - medical

  • Department of Vascular Surgery

Research Output (17)

Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemia

Wijnand Joep G J, van Koeverden Ian D, Teraa Martin, Spreen Marlon I, Mali Willem P T M, van Overhagen Hans, Pasterkamp Gerard, de Borst Gert J, Conte Michael S, Gremmels Hendrik, Verhaar Marianne C 1 mrt 2020, In: Journal of Vascular Surgery. 71 , p. 869-879 11 p.

Applicability of Transcutaneous Oxygen Tension Measurement in the Assessment of Chronic Limb-Threatening Ischemia

Leenstra Bernard, Wijnand Joep, Verhoeven Bart, Koning Olivier, Teraa Martin, Verhaar Marianne C, de Borst Gert J mrt 2020, In: Angiology. 71 , p. 208-216 9 p.

A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia

Gremmels Hendrik, Teraa Martin, de Jager Saskia C.A., Pasterkamp Gerard, de Borst Gert J., Verhaar Marianne C. 1 dec 2019, In: Scientific Reports. 9

Exhaustion of the bone marrow progenitor cell reserve is associated with major events in severe limb ischemia

Gremmels Hendrik, van Rhijn-Brouwer Femke C C, Papazova Diana A, Fledderus Joost O, Teraa Martin, Verhaar Marianne C, 30 mrt 2019, In: Angiogenesis. 22 , p. 411-420 10 p.

High and immeasurable ankle-brachial index as predictor of poor amputation-free survival in critical limb ischemia

Spreen Marlon I, Gremmels Hendrik, Teraa Martin, Sprengers Ralf W, Martens Jasper M, Verhaar Marianne C, Wever Jan J, de Borst Gert J, Vos Jan A, Mali Willem P Th M, van Overhagen Hans, jun 2018, In: Journal of Vascular Surgery. 67 , p. 1864-1871.e3

Growth differentiation factor 15 is associated with major amputation and mortality in patients with peripheral artery disease

De Haan Judith J., Haitjema Saskia, den Ruijter Hester M., Pasterkamp Gerard, de Borst Gert J., Teraa Martin, Verhaar Marianne C., Gremmels Hendrik, de Jager Saskia C.A. 30 aug 2017, In: Journal of the American Heart Association. 6

Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia

Wijnand Joep G.J., Teraa Martin, Gremmels Hendrik, van Rhijn-Brouwer Femke C.C., de Borst Gert J., Verhaar Marianne C. 2017, In: Journal of Vascular Surgery. 67 , p. 656-661 6 p.

Diabetes Mellitus Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia:Pooled Data From Two Randomized Controlled Trials

Spreen Marlon I, Gremmels Hendrik, Teraa Martin, Sprengers Ralf W, Verhaar Marianne C, Statius van Eps Randolph G, de Vries Jean-Paul P M, Mali Willem P.Th.M. , van Overhagen Hans, 9 sep 2016, In: Diabetes Care. 39 , p. 2058-2064

DIFFERENTIAL PLATELET ACTIVATION AFTER P2Y12 INHIBITION

Leunissen T. C., Wisman P. P., van Holten T., de Groot P., Remijn J., Frans M., de Borst G-J, Teraa M., Verhaar M., Urbanus R., Roest M. mei 2016, In: Thrombosis Research. 141 , p. S15-S15

Quality of Life after Treatment with Autologous Bone Marrow Derived Cells in No Option Severe Limb Ischemia

Peeters Weem S. M O, Teraa M., Den Ruijter H. M., De Borst G. J., Verhaar M. C., Moll F. L. 1 jan 2016, In: European Journal of Vascular and Endovascular Surgery. 51 , p. 83-89 7 p.

All Research Output (17)